These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31727975)

  • 1. Frequency and Clinical Associating Factors of Valvular Heart Disease in Asymptomatic Korean Adults.
    Kim MS; Cho SJ; Park SJ; Cho SW; Choi SH; Kim HS; Carriere K; Kim EK; Chang SA; Lee SC; Park SW
    Sci Rep; 2019 Nov; 9(1):16741. PubMed ID: 31727975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of asymptomatic valvular heart disease in the elderly population: a community-based echocardiographic study.
    Tsampasian V; Militaru C; Parasuraman SK; Loudon BL; Lowery C; Rudd A; Srinivasan J; Singh S; Dwivedi G; Mahadavan G; Dawson D; Clark A; Vassiliou VS; Frenneaux MP
    Eur Heart J Cardiovasc Imaging; 2024 Jul; 25(8):1051-1058. PubMed ID: 38925103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the Severity of Heart Valve Stenosis and Regurgitation Among a Diverse Population Within an Integrated Health Care System: Natural Language Processing Approach.
    Xie F; Lee MS; Allahwerdy S; Getahun D; Wessler B; Chen W
    JMIR Cardio; 2024 Sep; 8():e60503. PubMed ID: 39348175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP Valvular Heart Disease II survey.
    Dreyfus J; Komar M; Attias D; De Bonis M; Ruschitzka F; Popescu BA; Laroche C; Tribouilloy C; Bogachev Prokophiev A; Mizariene V; Bax JJ; Maggioni AP; Messika-Zeitoun D; Vahanian A; Iung B;
    Eur J Heart Fail; 2024 Apr; 26(4):994-1003. PubMed ID: 38374610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of patients with moderate or severe valvular heart disease].
    Gao H; Lei YZ; Huang HY; Xu X; Zhang C; Zhu JF; Li LH; Zeng M; Chen SH; He JL; Chen YX; Zhang ZH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Oct; 52(10):1200-1206. PubMed ID: 39428370
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients.
    Gardezi SKM; Myerson SG; Chambers J; Coffey S; d'Arcy J; Hobbs FDR; Holt J; Kennedy A; Loudon M; Prendergast A; Prothero A; Wilson J; Prendergast BD
    Heart; 2018 Nov; 104(22):1832-1835. PubMed ID: 29794244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study.
    Andell P; Li X; Martinsson A; Andersson C; Stagmo M; Zöller B; Sundquist K; Smith JG
    Heart; 2017 Nov; 103(21):1696-1703. PubMed ID: 28432156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of long-term exposure to traffic-related air pollution with risk of valvular heart disease based on a cross-sectional study.
    Pang Y; Liu S; Yan L; Wang Q; Li L; Chu C; Ning J; Zhang B; Wang X; Ma S; Su D; Zhang R; Niu Y
    Ecotoxicol Environ Saf; 2021 Feb; 209():111753. PubMed ID: 33348255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.
    Hojo Y; Kumakura H; Kanai H; Iwasaki T; Ichikawa S; Kurabayashi M
    Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):492-7. PubMed ID: 26758409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, China.
    Shu C; Chen S; Qin T; Fu Z; Sun T; Xie M; Zhang L; Dong N; Yin P
    Sci Rep; 2016 Jun; 6():27253. PubMed ID: 27250873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac valvular surgery and history of anorectic drug intake: A retrospective study of a large population of benfluorex-exposed patients.
    Laurent M; Ennezat PV; Malergue MC; Bruneval P;
    Arch Cardiovasc Dis; 2022; 115(6-7):348-358. PubMed ID: 35697655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey.
    Mascherbauer J; Kammerlander A; Nitsche C; Bax J; Delgado V; Evangelista A; Laroche C; Maggioni AP; Magne J; Vahanian A; Iung B
    Eur Heart J; 2024 Oct; 45(37):3818-3833. PubMed ID: 39212374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and correlates of physiological valvular regurgitation in healthy subjects.
    Okura H; Takada Y; Yamabe A; Ozaki T; Yamagishi H; Toda I; Yoshiyama M; Yoshikawa J; Yoshida K
    Circ J; 2011; 75(11):2699-704. PubMed ID: 21881247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older.
    Rezzoug N; Vaes B; de Meester C; Degryse J; Van Pottelbergh G; Mathei C; Adriaensen W; Pasquet A; Vanoverschelde JL
    BMC Cardiovasc Disord; 2016 Jan; 16():7. PubMed ID: 26754575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience.
    Manjunath CN; Srinivas P; Ravindranath KS; Dhanalakshmi C
    Indian Heart J; 2014; 66(3):320-6. PubMed ID: 24973838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic Profile of Patients With Valvular Heart Disease in Korea: A Nationwide Hospital-Based Registry Study.
    Choi YJ; Son JW; Kim EK; Kim IC; Kim HY; Seo JS; Sun BJ; Shim CY; Yoon SJ; Lee S; Lee SH; Park JB; Kang DH
    J Cardiovasc Imaging; 2023 Jan; 31(1):51-61. PubMed ID: 36693346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Shelbaya K; Claggett B; Dorbala P; Skali H; Solomon SD; Matsushita K; Konety S; Mosley TH; Shah AM
    Circulation; 2023 Feb; 147(8):638-649. PubMed ID: 36524478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.
    d'Arcy JL; Coffey S; Loudon MA; Kennedy A; Pearson-Stuttard J; Birks J; Frangou E; Farmer AJ; Mant D; Wilson J; Myerson SG; Prendergast BD
    Eur Heart J; 2016 Dec; 37(47):3515-3522. PubMed ID: 27354049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
    Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
    Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.